glp-1 receptor agonists inflammation
Why Semaglutide Pre‑Surgery Fails? 3 Hidden Risks
In a 2023 analysis, 22% of patients on semaglutide experienced postoperative complications, revealing three hidden risks that can undermine pre-surgical success. These risks stem from unexpected changes in inflammation, metabolic markers, and glycemic control that affect joint healing and implant stability. Understanding how GLP-1 receptor agonists reshape the surgical landscape